Mechanisms of Enteric Burkholderia psuedomallei infection
肠道假鼻疽伯克霍尔德氏菌感染的机制
基本信息
- 批准号:8028304
- 负责人:
- 金额:$ 18.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-01-01 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:AbscessAcuteAddressAntibioticsAustraliaBacteriaBreathingBurkholderiaBurkholderia pseudomalleiCellsCentral AmericaChronicContractsCutaneousDataDiagnosisEnteralFoodFrequenciesGastrointestinal tract structureGoalsHealthHumanInfectionInjuryInternationalIntestinesKnowledgeLeadMaintenanceModelingMusOralOrganOrganismPathogenesisPhenotypePropertyResistanceRiskRoleRouteSepsisSkinSoilSouth AmericaSoutheastern AsiaVirulenceVirulentWaterantimicrobialbaseenteric pathogenin vitro Assaymouse modelpathogentreatment strategyvaccination strategy
项目摘要
DESCRIPTION (provided by applicant): Burkholderia pseudomallei (Bp) is a Gram-negative bacterial pathogen that can cause a variety of difficult-to-treat infections in humans ranging from acute sepsis to chronic abscesses. While Bp is endemic in Southeast Asia and northern Australia, infections are now being diagnosed with increasing frequency around the world, including in Central and South America. Therefore, it is likely that Bp infections will soon be identified in the U.S. Though infection with Bp was previously thought to occur by inhalation or skin inoculation, our new studies indicate that Bp is actually a primary enteric pathogen, which can readily establish acute or persistent GI tract infection following oral inoculation in mouse models. However, at present essentially nothing is known regarding the pathogenesis of enteric infection with Bp. Therefore, the studies proposed here are intended to fill a critical void in our understanding of pathogenesis of infection with this important and emerging bacterial pathogen. First, we will use the mouse infection model of Bp infection to determine whether most or all strains of Bp can establish enteric infection and to identify virulent and avirulent isolates. Second, we will use the model to define the role of the intestine as a reservoir for Bp infection and to identify cells in the GI tract where the organism is maintained during chronic infection. Last, we will investigate how Bp is disseminated to other organs during chronic enteric infection. The information generated in these studies will substantially alter our view of Bp as a pathogen and also lead to a reassessment of the risks posed by oral Bp infection.
PUBLIC HEALTH RELEVANCE: Burkholderia pseudomallei is an important and dangerous bacterial pathogen that appears in recent years to be spreading around the world, including Central and South America. This organism is particularly dangerous because it is able to survive for years in soil and water, is very resistant to most antibiotics, and can cause rapidly fatal infections in humans. Previously it was assumed that the organism was contracted only by inhalation or skin injury, but our new data indicate that B. pseudomallei is also very infectious orally and causes chronic intestinal infection with fecal shedding. We will therefore study the mechanisms that allow B. pseudomallei to infect the intestinal tract, using mouse models of infection.
描述(由申请人提供):类鼻疽伯克霍尔德氏菌(Bp)是一种革兰氏阴性细菌病原体,可引起人类多种难以治疗的感染,从急性败血症到慢性脓肿。虽然 Bp 在东南亚和澳大利亚北部流行,但现在世界各地(包括中美洲和南美洲)的感染诊断频率不断增加。因此,Bp 感染很可能很快就会在美国被发现。虽然 Bp 感染以前被认为是通过吸入或皮肤接种而发生的,但我们的新研究表明,Bp 实际上是一种主要的肠道病原体,很容易形成急性或持续性感染。小鼠模型口服接种后胃肠道感染。然而,目前对于 Bp 肠道感染的发病机制基本上一无所知。因此,这里提出的研究旨在填补我们对这种重要的新兴细菌病原体感染发病机制的理解中的一个关键空白。首先,我们将使用 Bp 感染的小鼠感染模型来确定大多数或所有 Bp 菌株是否可以建立肠道感染,并鉴定强毒力和无毒力分离株。其次,我们将使用该模型来定义肠道作为 Bp 感染储存库的作用,并识别胃肠道中的细胞,在慢性感染期间,微生物在胃肠道中得以维持。最后,我们将研究慢性肠道感染期间 Bp 如何传播到其他器官。这些研究中产生的信息将极大地改变我们对 Bp 作为病原体的看法,并导致人们重新评估口腔 Bp 感染所带来的风险。
公共卫生相关性:鼻疽伯克霍尔德氏菌是一种重要且危险的细菌病原体,近年来似乎在世界各地传播,包括中美洲和南美洲。这种生物体特别危险,因为它能够在土壤和水中存活多年,对大多数抗生素具有很强的抵抗力,并且可以迅速引起人类致命的感染。此前人们认为该生物体仅通过吸入或皮肤损伤而感染,但我们的新数据表明,类鼻疽伯克氏菌经口传染性也很强,可导致慢性肠道感染并伴有粪便排出。因此,我们将使用小鼠感染模型来研究类鼻疽伯克氏菌感染肠道的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven W. Dow其他文献
IdeaGens: Enabling Expert Facilitation of Crowd Brainstorming
IdeaGens:专家促进群体头脑风暴
- DOI:
10.1145/2818052.2874313 - 发表时间:
2016 - 期刊:
- 影响因子:0
- 作者:
Joel Chan;Steven Dang;Steven W. Dow - 通讯作者:
Steven W. Dow
Elevated interleukin 6 activity in aqueous humor of cats with uveitis
葡萄膜炎猫房水中白细胞介素 6 活性升高
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:1.8
- 作者:
M. Lappin;Steven W. Dow;J. Reif;M. Chavkin - 通讯作者:
M. Chavkin
Social Network, Web Forum, or Task Market?: Comparing Different Crowd Genres for Design Feedback Exchange
社交网络、网络论坛还是任务市场?:比较不同人群类型的设计反馈交换
- DOI:
- 发表时间:
2016 - 期刊:
- 影响因子:0
- 作者:
Yu;Steven W. Dow;E. Gerber;B. Bailey - 通讯作者:
B. Bailey
Mobile ADVICE: an accessible device for visually impaired capability enhancement
Mobile ADVICE:用于增强视障人士能力的无障碍设备
- DOI:
- 发表时间:
2003 - 期刊:
- 影响因子:0
- 作者:
Robert A. Amar;Steven W. Dow;Richard Gordon;M. R. Hamid;Chad Sellers - 通讯作者:
Chad Sellers
Using Anonymity and Communal Efforts to Improve Quality of Crowdsourced Feedback
利用匿名和共同努力来提高众包反馈的质量
- DOI:
10.1609/hcomp.v3i1.13229 - 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
Julie Hui;A. Glenn;Rachel Jue;E. Gerber;Steven W. Dow - 通讯作者:
Steven W. Dow
Steven W. Dow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven W. Dow', 18)}}的其他基金
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
优化针对犬自发性骨肉瘤肿瘤微环境的新型免疫治疗组合
- 批准号:
10488605 - 财政年份:2017
- 资助金额:
$ 18.07万 - 项目类别:
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
优化针对犬自发性骨肉瘤肿瘤微环境的新型免疫治疗组合
- 批准号:
10260606 - 财政年份:2017
- 资助金额:
$ 18.07万 - 项目类别:
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
优化针对犬自发性骨肉瘤肿瘤微环境的新型免疫治疗组合
- 批准号:
10247894 - 财政年份:2017
- 资助金额:
$ 18.07万 - 项目类别:
Mechanisms of Enteric Burkholderia psuedomallei infection
肠道假鼻疽伯克霍尔德氏菌感染的机制
- 批准号:
8207208 - 财政年份:2011
- 资助金额:
$ 18.07万 - 项目类别:
Mucosal immunization for cross-protection against pneumonic burkholderia
粘膜免疫对肺炎伯克霍尔德氏菌的交叉保护
- 批准号:
8261421 - 财政年份:2011
- 资助金额:
$ 18.07万 - 项目类别:
Mucosal immunization for cross-protection against pneumonic burkholderia
粘膜免疫对肺炎伯克霍尔德氏菌的交叉保护
- 批准号:
7675566 - 财政年份:2009
- 资助金额:
$ 18.07万 - 项目类别:
Innate Immunity to Pneumonic Burkholderia Infection
对肺炎伯克霍尔德氏菌感染的先天免疫
- 批准号:
7641020 - 财政年份:2008
- 资助金额:
$ 18.07万 - 项目类别:
Innate Immunity to Pneumonic Burkholderia Infection
对肺炎伯克霍尔德氏菌感染的先天免疫
- 批准号:
7126628 - 财政年份:2005
- 资助金额:
$ 18.07万 - 项目类别:
Antigen Presentation and Pulmonary Immunity to Plague
抗原呈递和肺对鼠疫的免疫力
- 批准号:
6788190 - 财政年份:2003
- 资助金额:
$ 18.07万 - 项目类别:
Antigen Presentation and Pulmonary Immunity to Plague
抗原呈递和肺对鼠疫的免疫力
- 批准号:
6861718 - 财政年份:2003
- 资助金额:
$ 18.07万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Development of clinically translatable MRI methodologies for the thoracic spinal cord
胸脊髓临床可转化 MRI 方法的开发
- 批准号:
10728689 - 财政年份:2023
- 资助金额:
$ 18.07万 - 项目类别:
Inhaled tigecycline therapy for pulmonary M. abscessus infections
吸入替加环素治疗肺部脓肿分枝杆菌感染
- 批准号:
10312329 - 财政年份:2021
- 资助金额:
$ 18.07万 - 项目类别:
Inhaled tigecycline therapy for pulmonary M. abscessus infections
吸入替加环素治疗肺部脓肿分枝杆菌感染
- 批准号:
10437923 - 财政年份:2021
- 资助金额:
$ 18.07万 - 项目类别:
Retention and Re-Engagement in Treatment for Addiction following Serious Injection Related Infections (RETAIN)
严重注射相关感染后保留和重新参与成瘾治疗(RETAIN)
- 批准号:
10282857 - 财政年份:2021
- 资助金额:
$ 18.07万 - 项目类别:
Retention and Re-Engagement in Treatment for Addiction following Serious Injection Related Infections (RETAIN)
严重注射相关感染后保留和重新参与成瘾治疗(RETAIN)
- 批准号:
10428651 - 财政年份:2021
- 资助金额:
$ 18.07万 - 项目类别: